文献速递食管与纵隔外科

食管癌诱导放疗剂量对食管切除术后结局的影响

Induction Radiation Therapy for Esophageal Cancer: Does Dose Affect Outcomes?
PubMed 文献 · Ann Thorac Surg · 2018-11-13

基于美国国家癌症数据库2004–2014年食管癌诱导放疗后行食管切除术的患者,按剂量分为低剂量(<40 Gy)、标准剂量(40–50.4 Gy)和高剂量(>50.4 Gy)。高剂量与更高30天死亡率相关但未改善肿瘤反应,低剂量与更差肿瘤反应相关但未降低死亡风险;标准剂量内50.4 Gy较45 Gy有更高pCR率且不增加30天死亡率。

要点

  • 高剂量诱导放疗(>50.4 Gy)增加食管切除术后30天死亡风险,且未显著改善肿瘤反应。
  • 低剂量诱导放疗(<40 Gy)与更差肿瘤反应相关,且未降低围手术期死亡风险。
  • 标准剂量内50.4 Gy较45 Gy有更高pCR率,且不影响30天死亡率。

核心结论

  • 高剂量诱导放疗(>50.4 Gy)与食管切除术后围手术期死亡增加相关,且未显著改善肿瘤反应。
  • 低剂量放疗(<40 Gy)与更差肿瘤反应相关,且未降低围手术期死亡风险。
  • 标准剂量范围内,50.4 Gy较45 Gy与更高pCR可能性相关,且不增加围手术期死亡率。

研究设计与样本

  • 回顾性队列研究,数据来自美国国家癌症数据库(National Cancer Database)。
  • 纳入2004–2014年接受诱导放疗(30–70 Gy)后行食管切除术的患者,共10,738例(84.7%)接受标准剂量、1,329例(10.5%)低剂量、608例(4.8%)高剂量。
  • 按剂量分为低剂量(<40 Gy)、标准剂量(40–50.4 Gy)和高剂量(>50.4 Gy),比较围手术期结局和总生存,并亚组比较45 Gy与50.4 Gy。

主要发现

  • 标准剂量放疗比例从2004年69.7%增至2014年93.6%(p < 0.001)。
  • 随剂量增加,病理完全缓解(pCR)率升高(低:11.7%,标准:16.2%,高:21.0%;p < 0.001),降期率亦升高(低:52.0%,标准:56.4%,高:63.1%;p = 0.001)。
  • 多变量分析中,与标准剂量相比,高剂量与更高30天死亡率相关(OR 2.11;p < 0.001),但未提高降期或pCR可能性。
  • 低剂量与更低降期可能性(OR 0.85;p = 0.04)和更低pCR可能性(OR 0.67;p < 0.001)相关,且未降低30天死亡风险。
  • 与45 Gy相比,50.4 Gy与更高pCR可能性相关(OR 1.12;p = 0.04),且不影响30天死亡率。

关键数值与推荐

  • 高剂量诱导放疗定义为>50.4 Gy,标准剂量为40–50.4 Gy,低剂量为<40 Gy。
  • 高剂量vs标准剂量:30天死亡率OR 2.11(p < 0.001)。
  • 低剂量vs标准剂量:降期OR 0.85(p = 0.04),pCR OR 0.67(p < 0.001)。
  • 50.4 Gy vs 45 Gy:pCR OR 1.12(p = 0.04)。

临床怎么用

  • 食管癌诱导放疗应优先选择标准剂量范围(40–50.4 Gy),避免高剂量(>50.4 Gy)以降低围手术期死亡风险。
  • 标准剂量内可考虑50.4 Gy而非45 Gy,以提高pCR可能性且不增加30天死亡率。
  • 避免低剂量(<40 Gy),因其与更差肿瘤反应相关且未降低围手术期死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Wide variation is seen in the dosage of preoperative induction radiation therapy for esophageal cancer. We investigated associations between outcomes after esophagectomy and dosage of induction radiation therapy. METHODS: Patients undergoing induction radiation therapy (30 to 70 Gy), followed by esophagectomy, were identified from the National Cancer Database and classified as low (<40 Gy), standard (40 to 50.4 Gy), and high dose (>50.4 Gy). Perioperative outcomes and overall survival were compared. Subgroup analysis compared two common dosages: 45 Gy and 50.4 Gy. RESULTS: From 2004 to 2014, 10,738 patients (84.7%) received standard-dose radiation, increasing from 69.7% in 2004 to 93.6% in 2014 (p < 0.001), 1,329 (10.5%) received low-dose radiation, and 608 (4.8%) received high-dose radiation. Higher rates of pathologic complete response (pCR; low: 11.7%, standard: 16.2%, high: 21.0%; p < 0.001) and downstaging (low: 52.0%, standard: 56.4%, high: 63.1%, p = 0.001) were observed as the dosage increased. On multivariable analysis, compared with standard-dose, high-dose radiation was associated with higher 30-day mortality (odds ratio [OR], 2.11; p < 0.001) without a higher likelihood of downstaging or pCR. Low-dose radiation was associated with lower likelihood of downstaging (OR, 0.85; p = 0.04) and pCR (OR, 0.67; p < 0.001) without lowering the risk of 30-day mortality. The dose of 50.4 Gy was associated with higher likelihood of pCR (OR, 1.12; p = 0.04), without affecting 30-day mortality, compared with 45 Gy. CONCLUSIONS: High-dose induction radiation (>50.4 Gy) is associated with increased perioperative death after esophagectomy, without a significant improvement in tumor response. Low-dose radiation (<30 Gy) is associated with worse tumor response without a lower risk of perioperative death. Within standard dosages, 50.4 Gy is associated with higher likelihood of pCR without adversely affecting perioperative mortality compared with 45 Gy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Semenkovich TR, Samson PP, Hudson JL, et al. Induction Radiation Therapy for Esophageal Cancer: Does Dose Affect Outcomes? Ann Thorac Surg. 2018. PMID: 30444988. doi:10.1016/j.athoracsur.2018.09.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。